| 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management F Gomollón, A Dignass, V Annese, H Tilg, G Van Assche, JO Lindsay, ... Journal of Crohn's and Colitis 11 (1), 3-25, 2017 | 2207 | 2017 |
| Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target L Peyrin-Biroulet, W Sandborn, BE Sands, W Reinisch, W Bemelman, ... Official journal of the American College of Gastroenterology| ACG 110 (9 …, 2015 | 1826 | 2015 |
| ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications C Maaser, A Sturm, SR Vavricka, T Kucharzik, G Fiorino, V Annese, ... Journal of Crohn's and Colitis 13 (2), 144-164K, 2019 | 1231 | 2019 |
| ECCO guidelines on therapeutics in Crohn's disease: medical treatment J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ... Journal of Crohn's and Colitis 14 (1), 4-22, 2020 | 1118 | 2020 |
| The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease CJ Van der Woude, S Ardizzone, MB Bengtson, G Fiorino, G Fraser, ... Journal of Crohn's and Colitis 9 (2), 107-124, 2015 | 527 | 2015 |
| ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ... Journal of Crohn's and Colitis 14 (2), 155-168, 2020 | 476 | 2020 |
| ECCO guidelines on therapeutics in ulcerative colitis: medical treatment T Raine, S Bonovas, J Burisch, T Kucharzik, M Adamina, V Annese, ... Journal of Crohn's and Colitis 16 (1), 2-17, 2022 | 468 | 2022 |
| European evidence-based consensus: inflammatory bowel disease and malignancies V Annese, L Beaugerie, L Egan, L Biancone, C Bolling, C Brandts, ... Journal of Crohn's and Colitis 9 (11), 945-965, 2015 | 452 | 2015 |
| Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis S Bonovas, G Fiorino, M Allocca, T Lytras, GK Nikolopoulos, ... Clinical Gastroenterology and Hepatology 14 (10), 1385-1397. e10, 2016 | 374 | 2016 |
| Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study C Bezzio, S Saibeni, A Variola, M Allocca, A Massari, V Gerardi, V Casini, ... Gut 69 (7), 1213-1217, 2020 | 349 | 2020 |
| Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease B Pariente, JY Mary, S Danese, Y Chowers, P De Cruz, G D’Haens, ... Gastroenterology 148 (1), 52-63. e3, 2015 | 328 | 2015 |
| ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects A Sturm, C Maaser, E Calabrese, V Annese, G Fiorino, T Kucharzik, ... Journal of Crohn's and Colitis 13 (3), 273-284, 2019 | 312 | 2019 |
| Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease G Fiorino, C Bonifacio, L Peyrin-Biroulet, F Minuti, A Repici, A Spinelli, ... Inflammatory bowel diseases 17 (5), 1073-1080, 2011 | 274 | 2011 |
| ECCO position statement on the use of biosimilars for inflammatory bowel disease—an update S Danese, G Fiorino, T Raine, M Ferrante, K Kemp, J Kierkus, PL Lakatos, ... Journal of Crohn's and Colitis 11 (1), 26-34, 2017 | 267 | 2017 |
| Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis S Danese, G Fiorino, L Peyrin-Biroulet, E Lucenteforte, G Virgili, L Moja, ... Annals of internal medicine 160 (10), 704-711, 2014 | 258 | 2014 |
| European Crohn’s and Colitis Organisation [ECCO] and the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] ECCO-ESGAR Guideline for Diagnostic Assessment in … C Maaser, A Sturm, SR Vavricka, T Kucharzik, G Fiorino, V Annese, ... J Crohns Colitis 13 (2), 144-164, 2019 | 233 | 2019 |
| Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease NT Ventham, NA Kennedy, AT Adams, R Kalla, S Heath, KR O'leary, ... Nature communications 7 (1), 13507, 2016 | 227 | 2016 |
| Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study G Fiorino, L Peyrin-Biroulet, P Naccarato, H Szabò, OR Sociale, ... Inflammatory bowel diseases 18 (6), 1042-1047, 2012 | 198 | 2012 |
| IOIBD technical review on endoscopic indices for Crohn's disease clinical trials L Vuitton, P Marteau, WJ Sandborn, BG Levesque, B Feagan, S Vermeire, ... Gut 65 (9), 1447-1455, 2016 | 189 | 2016 |
| Long-term safety ofin uteroexposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study M Chaparro, A Verreth, T Lobaton, E Gravito-Soares, M Julsgaard, ... Official journal of the American College of Gastroenterology| ACG 113 (3 …, 2018 | 181 | 2018 |
